Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dermalex Eczema versus hydrocortisone or emollient in mild to moderate atopic dermatitis
NL-OMON41112Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of hydrocortisone in atopic dermatitis (AD) (3 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Time to clinical improvement. Started Sep 2014; status: active, not recruiting.
02
Drugs
hydrocortisone
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NL-OMON41112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41112.